Rabia T. K.
About Rabia T. K.
Rabia Khan, CEO with a PhD in Human Genetics and an MBA, has held influential roles in major biotech firms and is dedicated to promoting diversity in STEM.
Rabia Khan CEO
Rabia Khan serves as the CEO of her current organization, leading with a strong background in human genetics and business administration. She brings extensive experience from her previous roles in the biotechnology and pharmaceutical industries. Her leadership is characterized by strategic vision and operational excellence, drawing from her profound academic background and industry expertise.
Rabia Khan Education and Expertise
Rabia Khan holds a PhD in Human Genetics, equipping her with advanced knowledge in genetic sciences. In addition, she possesses an MBA, blending her scientific expertise with strategic business management skills. This unique combination allows her to effectively bridge the gap between scientific research and commercial application, enhancing her leadership capabilities in the biotech sector.
Rabia Khan Background
Born and raised in Pakistan, Rabia Khan's early life and cultural background have influenced her passion for diversity and inclusion in the STEM fields. Her journey from Pakistan to becoming a leading figure in the biotech industry highlights her commitment to making impactful contributions and breaking down barriers for underrepresented groups in science and technology.
Rabia Khan Achievements
Throughout her career, Rabia Khan has been recognized for her leadership and contributions to the biotech industry. She was named among the '50 Movers and Shakers in BioBusiness' and '30 Rising Leaders in Biotech' in 2020. These accolades reflect her influence and potential in driving innovation within the sector.
Rabia Khan at Sensyne Health Plc
As Managing Director of Discovery Sciences at Sensyne Health Plc, Rabia Khan was instrumental in establishing the scientific strategy. She built the data science and discovery teams and spearheaded strategic pharma partnerships with major companies including Bayer, BMS, Roche, and Alexion. Her role was pivotal in the advancement of discovery sciences within the organization.